Haloxazolam
From Wikipedia, the free encyclopedia
|
Haloxazolam
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C17H14BrFN2O2 |
| Mol. mass | 377.208 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Haloxazolam (marketed under brand name Somelin) is a drug which is a benzodiazepine derivative.
Haloxazolam is not approved for sale in the United States or Canada.
|
|||||||||||||||||||||||||||||

